New Appetite-Suppressing drug shows promise in early trial for weight loss
Disease control
Completed
This study tested a daily injection called ROSE-010 in 40 overweight or obese women to see if it reduces how much they eat at lunch. The drug is similar to natural hormones that control appetite. The goal is to help manage weight by curbing hunger and increasing fullness.
Phase: PHASE2 • Sponsor: Rose Pharma Inc • Aim: Disease control
Last updated May 26, 2026 11:16 UTC